glp-1 trial results today GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction Comparing Semaglutide, Liraglutide, and Tirzepatide:

EAA 3 1

As with GLP-1 prior to the advent of long-acting analogs, incomplete translational tools may explain the gap between strong preclinical biology and equivocal human data

Even though the FDA approved Wegovythe same semaglutide molecule at higher dosesspecifically for chronic weight management in 2021, most health plans treat it as an off-label use

Note that specific stopping rules apply to some medicationsfor example, Saxenda (liraglutide 3 mg) should be discontinued if a 5% weight reduction is not achieved after 12 weeks at the full dose

Plus, if you have any bouts of diarrhoea, youll need to replenish fluids